Dr. Mara Aldenhoff
Hematologist, 25 years in translational pharmaceuticals. PhD, KU Leuven.
Veltrane Laboratories is an independent Belgian pharmaceutical lab founded in 1998 in a single Brussels cleanroom. Twenty-five years later, we serve patients across Europe but the question that started us is still the one we answer every morning:
"Can you prove what's inside the bottle is exactly what the label says?"
Our answer is built on three pillars: rigorous pharmaceutical science, transparent supply chains, and a public verification platform that puts proof directly in a patient's hand.

Make every medicine traceable, verifiable, and safe — anywhere in Europe, in seconds.
A future where counterfeit medicine is eradicated by open, patient-facing verification technology.
Integrity, scientific rigor, accessibility, and an unshakeable focus on the patient at the end of the chain.
In 1998, a group of Belgian pharmacists pooled their savings to open a 60-square-meter cleanroom in Brussels. Their first product was a precise antibiotic suspension; their first customer was a community hospital in Liège.
That product included something unusual at the time: a printed batch number tied to a public registry. Counterfeits dropped to zero within six months. The idea outgrew the product, and Veltrane Laboratories was born.
Today, every product we ship — from antibiotics to cardiovascular therapies — carries a cryptographically signed QR seal. Patients, pharmacists, and regulators can verify it instantly, for free, forever.
A 39-amino-acid synthetic peptide — and the first dual GIP / GLP-1 receptor agonist we manufacture under our verified seal.
Hover any node to expand · the orbit pauses while you read
A multidisciplinary team of clinicians, engineers, and ethicists.
Hematologist, 25 years in translational pharmaceuticals. PhD, KU Leuven.
Biochemist specializing in molecular assay design. Former EMA advisor.
Engineer behind the Verify Platform. Pioneer of cryptographic supply-chain ledgers.
Every product carries a public QR — anyone can verify, no account required.
60% of our team holds a doctorate in life sciences or biomedical engineering.
Distribution across all 27 EU member states — close to the patients we serve.
100% renewable energy across all facilities since 2022.
We publish our methods. Peer-reviewed papers in 30+ journals.
Every new product is co-designed with a patient advisory board.
From AI-assisted assay design to blockchain-verified batch logs.
Privately held — answerable to patients and clinicians, not shareholders alone.
"Veltrane gave our pharmacists something they had never had before — the ability to hand a phone to a worried parent and let them verify the medicine themselves. That is what trust looks like."